SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 6.00
+0.25 (4.26%)
Oct 15, 2026, 2:05 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 15.54 million as of October 15, 2026. It is the 37,143rd most valuable company in the world and the 807th biggest in the United Kingdom. Its market cap has decreased by 57.49% in one year.
Market Cap
15.54M
Enterprise Value
13.35M
Revenue
5.23M
Global Rank
Country Rank
#807 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has decreased from 15.73M to 15.54M, a decrease of -1.22%. That is a compound annual growth rate of -0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 15.54M | -61.88% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 25.51M |
| IXICO | 16.53M |
| Oxford BioDynamics | 14.79M |
| Fusion Antibodies | 12.52M |
| Aptamer Group | 10.97M |
| Palatin Technologies | 10.95M |
| Thalia Therapeutics | 10.65M |
| Genflow Biosciences | 9.92M |